Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 16 Jul 2018 – 20 Aug 2026, limited by ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative | Nifty 500 |
|---|---|---|
| 16 Jul 2018 | ₹100.00 | ₹100.00 |
| 19 Mar 2019 | ₹102.63 | ₹103.67 |
| 21 Nov 2019 | ₹104.85 | ₹105.21 |
| 24 Jul 2020 | ₹143.43 | ₹98.43 |
| 28 Mar 2021 | ₹177.17 | ₹131.61 |
| 29 Nov 2021 | ₹212.42 | ₹158.77 |
| 03 Aug 2022 | ₹201.31 | ₹161.17 |
| 06 Apr 2023 | ₹202.53 | ₹159.88 |
| 08 Dec 2023 | ₹279.39 | ₹202.61 |
| 11 Aug 2024 | ₹393.74 | ₹248.32 |
| 14 Apr 2025 | ₹383.74 | ₹224.81 |
| 17 Dec 2025 | ₹432.93 | ₹254.53 |
| 20 Aug 2026 | ₹476.16 | ₹254.71 |
| Metric | ICICI Prudential · Direct NAV ₹47.14 Very High risk ★★★★★ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +9.02% | +7.23% | |
| +23.18% | +16.94% | |
| +16.93% | +14.70% | |
| — | +15.10% | |
| +21.26% | +14.07% | |
| +21.21% | — | |
| +24.27% | +17.59% | |
| +23.91% | +16.29% | |
| — | +16.00% | |
| Risk | ||
| 13.65% | 15.69% | |
| 1.22 | 0.52 | |
| 1.76 | 0.73 | |
| -20.58% | -23.08% | |
| Nifty 500 | — | |
| +11.35% | +4.66% | |
| 0.81 | 0.96 | |
| 116.4% | 109.1% | |
| 60.1% | 91.0% | |
| 1.32% | 1.14% | |
| ₹6,476Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 78% | 45% | |
| Dharmesh Kakkad · 6.3y | — | |
| 16 Jul 2018 | — | |
| 35 | — | |
| 59.3% | — | |
| 4.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.